Form D — Strategikon Pharma, Inc.
0001722200-25-000002 · filed 2025-11-21
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $2,291,885
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Strategikon Pharma, Inc.
- CIK
- 1722200
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1 Sansome Street, 35th Floor PMB #40621
San Francisco, CA 94104 - Phone
- (609) 529-7806
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Anca Copaescu · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Mark Weinstein · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Nathanael Lentz · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Rob Hess · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Vincent Lepreux · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Debra Apruzzese · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Chris Codeanne · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Paulo Carvalho · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.